Support the show:

https://www.paypal.me/Truelifepodcast?locale.x=en_US

One on One Video Call W/George

https://tidycal.com/georgepmonty/60-minute-meeting

COMPOUND CLASS

Bifurcated tryptamine-salvinorin hybrid. The first of its structural class, insofar as its structural class is 'compounds that have decided to use your visual cortex as a portal rather than a canvas.' KATAPT-∞ is not a psychedelic in the conventional sense — it does not expand or distort perception. It inverts it. Specifically, it inverts the directionality of consciousness itself, which sounds like a metaphor and is not a metaphor and is in fact the most precise statement anyone has made in this document so far.

The compound class designation 'infinite valence' refers not to its bonding chemistry but to its topological effect on self-referential awareness. Standard psychedelics have a valence of 1: they take you somewhere. KATAPT-∞ has a valence of ∞ because the somewhere it takes you is inside the taking, which contains another taking, which contains another, which contains you, which contains the compound, which contains the somewhere, turtles all the way down except there are no turtles and there is no down and the concept of 'all the way' has just handed in its resignation.

HYPOTHETICAL PRECURSOR ROUTE

The synthesis requires two components that have never been in the same room together and would, if introduced, spend the first several minutes circling each other with the mutual wariness of two people who have heard about each other from a mutual friend and are not sure the mutual friend has their best interests at heart.

Component A: A tryptamine backbone — standard 5-MeO geometry, with one crucial modification at what we will call the observer position, which is not a real crystallographic designation and which the IUPAC nomenclature committee would find objectionable, but which is the only accurate way to describe the carbon atom responsible for the compound's relationship with the concept of witness.

Component B: A synthetic neosalvinorin fragment — specifically the furanyl lactone ring system that confers kappa-opioid selectivity in the natural compound, stripped of its terpenoid context and reattached to the tryptamine scaffold via a thiourea linker that is, in the theoretical literature, the most uncomfortable molecular bridge since the one in that dream where you are trying to get somewhere and the bridge keeps changing its mind about whether it is a bridge.

In a proposed condensation occurring at 37 degrees Celsius, zero humidity, and the ambient atmospheric pressure of a bathroom at approximately 7:14 on a Tuesday morning — the two components undergo what the theoretical literature calls a paradoxical aperture formation: a bond that simultaneously connects and inverts. The resulting molecule does not have a conventional structural formula. It has a structural question. The question is: which end is inside.

The answer, as the subject is about to discover, is both. Simultaneously. With gusto.

PROPOSED RECEPTOR PHARMACOLOGY

KATAPT-∞ acts simultaneously at three receptor systems, which is two more than well-behaved compounds typically act at, and which produces an effect that can be described, in clinical language, as a 'full-spectrum inversion of the observer-observed relationship,' and which can be described in plain language as: you are the mirror.

5-HT2A agonism: the standard psychedelic chassis. Signal amplification. Present-tense luminosity. The now becoming very, very, extremely now. This component is the stage.

Kappa-opioid agonism via the neosalvinorin fragment: the Salvia mechanism. Derealization of the observer. The brain's self-monitoring system — the part that says 'I am the one watching this' — begins to recognize itself as also being watched. By something. By the watching itself. By the thing that has always been looking through your eyes, which is not you in the way you thought you were you, and which has, it emerges, a personality.

Sigma-2 receptor modulation: the novel component. Sigma-2 receptors are implicated in intracellular membrane organization — the architecture of what's inside. KATAPT-∞'s sigma-2 activity does not alter this architecture. It makes it visible. Specifically, it makes the boundary between outside and inside — between the face you show the mirror and the mirror you are — temporarily, magnificently, irreversibly transparent. Not from the outside in. From the inside, which is also the outside. Which is the problem. Which is the feature.

The proposed result of this three-way binding profile: the subject does not have a psychedelic experience. The subject discovers that psychedelic experience has been having them. Has always been having them. Has in fact been running them as a kind of ongoing background process since the moment of their first self-aware thought, and has been waiting, with the patience of something that does not experience time the way things that experience time experience time, for the subject to finally look in the right mirror long enough to notice.

One on One Video call W/George
https://tidycal.com/georgepmonty/60-minute-meeting

Support the show:
https://www.paypal.me/Truelifepodcast?locale.x=en_US

🚨🚨Curious about the future of psychedelics? Imagine if Alan Watts started a secret society with Ram Dass and Hunter S. Thompson… now open the door.
Use Promocode TRUELIFE for Get 25% off monthly or 30% off the annual plan For the first year

https://www.district216.com/

Legal Disclaimer / Release of Liability for Podcast:
This content is for educational and informational purposes only. Nothing in this transmission constitutes legal, financial, or professional advice. I am not your lawyer, financial advisor, or telling you what to do.

This podcast documents historical events, analyzes publicly available information, and explores hypothetical scenarios. Any actions discussed are presented as educational examples of how systems work—not as instructions or recommendations.

You are solely responsible for your own decisions and actions. Any application of information presented here is at your own risk. I assume no liability for consequences of actions you choose to take.

By continuing to listen, you acknowledge that this content is educational commentary, that you’re responsible for researching applicable laws in your jurisdiction, and that you’ll consult appropriate professionals before taking any action that could affect your legal, financial, or personal situation.